Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00508)
| DIG Name |
Sorbitan monolaurate
|
||||
|---|---|---|---|---|---|
| Synonyms |
Sorbitan monolaurate; Span 20; Arlacel 20; Sorbitan laurate; UNII-6W9PS8B71J; 6W9PS8B71J; 1338-39-2; (R)-2-((2R,3R,4S)-3,4-dihydroxytetrahydrofuran-2-yl)-2-hydroxyethyl dodecanoate; 5959-89-7; [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate; Sorbitan laurate [INN]; Sorbitan, monododecanoate; Sorbitani lauras; Glycomul L; Glycomul LC; Alkamuls SML; Armotan ML; Dehymuls SML; Lonzest SML; Texnol SPT; 1,4-anhydro-6-O-dodecanoyl-D-glucitol; Laurate de sorbitan; Arlacel-20; Montane 20; Alkamuls S 20; Laurato de sorbitano; Radiasurf 7125; Sorgen 90; Kemotan S 20; Sorbitan, monolaurate; Emasol L 10; Nonion LP 20R; Nonion LR 20R; Sorbon S 20; Emasol 110; Rheodol SP-L 10; Disponil SML 100; Value SP 20; Atmer 100; Emsorb 2515; Ionet S 20; Emasol L 10(F); Nissan Nonion LP 20R; L 250 (ester); Anhydrosorbitol monolaurate; Lauric acid sorbitan ester; Rheodol Super SP-L 10; Emasol Super L 10(F); SCHEMBL3833; CCRIS 709; Sorbitan lauric acid monoester; Sorbitani lauras [INN-Latin]; CHEMBL3706389; DTXSID9027609; Sorbitan monolaurate [USAN:NF]; NRF 201; Sorbitan, esters, monododecanoate; SP-L 10; Laurate de sorbitan [INN-French]; ZINC8214457; EINECS 215-663-3; Laurato de sorbitano [INN-Spanish]; 1,4-Anhydro-D-glucitol, 6-dodecanoate; L 250; S0059; EC 215-663-3; Sorbitan monolaurate. (Compound usually contains also associated fatty acids.)
|
||||
| DIG Function |
Dispersing agent; Emulsifying agent; Solubilizing agent; Surfactant; Suspending agent; Vaccine adjuvant
|
||||
| Formula |
C18H34O6
|
||||
| Canonical SMILES |
CCCCCCCCCCCC(=O)OC[C@H]([C@@H]1[C@@H]([C@H](CO1)O)O)O
|
||||
| InChI |
1S/C18H34O6/c1-2-3-4-5-6-7-8-9-10-11-16(21)23-13-15(20)18-17(22)14(19)12-24-18/h14-15,17-20,22H,2-13H2,1H3/t14-,15+,17+,18+/m0/s1
|
||||
| InChIKey |
LWZFANDGMFTDAV-BURFUSLBSA-N
|
||||
| Physicochemical Properties | Molecular Weight | 346.5 | Topological Polar Surface Area | 96.2 | |
| XlogP | 3.7 | Complexity | 336 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 14 | ||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | ||
Full List of Drug(s) Co-administrated with This DIG